Guidelines proposed for newly defined Alzheimer’s-like brain disorder

Washington, DC - A recently recognized brain disorder that mimics clinical features of Alzheimer’s disease has for the first time been defined with recommended diagnostic criteria and other guidelines for advancing and catalyzing future research.

Daily folic acid supplement may reduce risk of gestational diabetes

Washington, DC - Taking a folic acid supplement daily before pregnancy may reduce the risk of gestational, or pregnancy-related, diabetes, according to a study by researchers at the National Institutes of Health and other institutions. The findings appear in Diabetes Care.

Flu Widespread Across U.S.; May Get Worse this Month

Washington, DC - Influenza is now widespread in 48 states and Puerto Rico, according to the latest report from the Centers for Disease Control (CDC), and the situation is likely to get worse over the next few weeks. The American Red Cross urges everyone six months of age and older to get their flu vaccine to be protected and has steps you can take to help keep the flu from spreading.

FDA approves new oral treatment for multiple sclerosis

Washington, DC - The U.S. Food and Drug Administration Friday approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.

Data demonstrating rising youth use of tobacco products

Washington, DC - Today, the U.S. Centers for Disease Control and Prevention (CDC) released additional data from our joint FDA/CDC 2018 National Youth Tobacco Survey.